Lido Advisors
AVXL icon

Lido Advisors’s Anavex Life Sciences AVXL Stock Holding History

Lido Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,100
Closed -$112K – 1836
2025
Q2 		$112K Hold
12,100
– – ﹤0.01% 1580
2025
Q1 		$104K Hold
12,100
– – ﹤0.01% 1443
2024
Q4 		$130K Hold
12,100
– – ﹤0.01% 1425
2024
Q3 		$68.7K Hold
12,100
– – ﹤0.01% 1418
2024
Q2 		$51.1K Sell
12,100
-274
-2% -$1.11K ﹤0.01% 1378
2024
Q1 		$63K Hold
12,374
– – ﹤0.01% 1342
2023
Q4 		$115K Hold
12,374
– – ﹤0.01% 1285
2023
Q3 		$81K Buy
12,374
+274
+2% +$2.18K ﹤0.01% 1150
2023
Q2 		$98.4K Buy
+12,100
New +$104K ﹤0.01% 1162

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return